Connect with us

Sonata (zaleplon)

Zaleplon (or SONATA®) is mainly prescribed to treat insomnia.

Status: ACTIVE

Class: Nonbenzodiazepine, Z-drug

FDA Approval: 1999

Dosage Forms: 5 mg, 10 mg

Biological Half-life: 1-1.5 hours

Side Effects: Sleepiness, dizziness, amnesia, lack of coordination, confusion, headache

Precautions: May cause significantly impaired driving or motor skills

Routes of Administration: Oral

Pregnancy Category: C (US)


© 2018 Mental Daily. All Rights Reserved.
Our content is for informational purposes and should not be used as medical or treatment recommendation.